CLIP OF THE WEEK
Curtis Sliwa and Grace-Marie Turner discuss the House and Senate health reform proposals and their impact on small businesses, medical professionals, and American health care consumers and patients in this radio interview.
Explore additional video and audio clips on free market, consumer-driven health solutions on the Health Reform Hub's Multimedia Page.
back to top 
GALEN IN THE NEWS
A Health Freedom Contract with America
Grace-Marie Turner, Galen Institute
The Orange County Register, 11/18/09
It’s time for lawmakers to stop insisting on a major overhaul of the health sector and reset the debate, Turner writes. Turner describes some common sense, patient-centered reforms that should be at the center of what could be called a “Health Freedom Contract” with the American people, including making insurance portable from job-to-job, allowing people to buy health insurance across state lines, increasing transparency in the health market, and addressing medical malpractice. Read More »
back to top 
Learning the Wrong Lessons from the Failure of ClintonCare
Grace-Marie Turner, Galen Institute
Sphere.com, 11/13/09
Democrats mistakenly believe they were tossed out of power in the 1994 elections because they failed to pass sweeping reform legislation, Turner writes, with leaders warning that failure to pass a health reform bill this year would be the worst political outcome for them. But polling data from 1994 show that voters punished elected officials at the polls for supporting the Clinton health reform plan, not for failing to pass it. Unless Democrats learn the right lessons from history, they may repeat the 1994 elections, where they are swept from power by an electorate angry that their leaders weren’t listening to their concerns about a very unpopular health reform plan. Read More »
Read more about health reform proposals on the Health Reform Hub >>
back to top 
HEALTH REFORM
A Breast Cancer Preview
The Wall Street Journal, 11/19/09
A government panel’s decision to toss out long-time guidelines for breast cancer screening is an all-too-instructive preview of political decisions about cost control and medical treatment that are at the heart of ObamaCare, The Wall Street Journal writes. The panel -– which included no oncologists and radiologists who best know the medical literature –- re-analyzed data with health care spending as a core concern. The effects of this new breast cancer cost-consciousness are likely to be large. More important for the future, every Democratic version of ObamaCare makes this panel an arbiter of the benefits that private insurers will be required to cover as they are converted into government contractors. What are now merely recommendations will become de facto rules, and under national health care, these kinds of cost analyses will inevitably become more common as government decides where finite tax dollars are allowed to go. Read More »
Explore comparative effectiveness issues on the Health Reform Hub >>
back to top 
Cutting Costs Means Getting Smarter
Joseph Antos, American Enterprise Institute
National Journal Expert Blogs: Health Care, 11/16/09
If we truly wish to create a sustainable health system, we cannot rely on easy-to-score budget cuts that keep intact payment methods and delivery methods that have produced unaffordable health care, Antos writes. The key is promoting smarter purchasing and smarter medical practice, and that means changing the way we do business. There is little in the reform bills to suggest that it won’t be business as usual. Read More »
The House bill, which leaves the flawed economic incentives of the fee-for-service system in place, will bend the cost curve upward, not downward, Antos writes in a blog post for The New York Times. Instead, reforms should focus on increasing competition in state insurance markets, reforming the tax exemption for health insurance, creating price transparency, and providing consumers better insurance options. Read More »
back to top 
An Individual Mandate for Health Insurance?
Thomas P. Miller, American Enterprise Institute
Georgetown Law Center, 11/16/09
The more rigid and narrowly defined an individual insurance mandate, the more likely will be legal challenges to it under statutory and constitutional law, Miller writes. It is important to understand and define the degree to which a mandate may limit an individual’s ability to direct resources for personal care. As such, the goal of achieving broader coverage could be accomplished through more indirect and less harmful ways. For example, we have achieved a non-mandate mandate in parts B and D of Medicare wherein you are charged higher premiums if you don’t opt in initially when first eligible. This has accomplished most of the universal coverage goal for the elderly and suggests that the indirect way of achieving broader coverage -– through the loss of a tax subsidy or the loss of the benefit -– gets you almost as far as trying to punish people directly to do it. Of course, the real limits with regard to an individual insurance purchasing mandate are not as much legal as they are political, economic, and administrative. Those latter factors ultimately will determine the scope and scale of any insurance mandate, as well as whether we have one or not. Read More »
Miller’s remarks are adapted from comments during a panel discussion of “The Constitutionality of Mandates to Purchase Health Insurance” at the April 27, 2009 Georgetown Law Center’s “Legal Solutions in Health Reform Spring Symposium.” Other panelists included Mark Hall of Wake Forest University School of Law and Len Nichols of New America Foundation. Read More »
back to top 
Health ‘Reform’ Gets a Failing Grade
Jeffrey S. Flier, Harvard Medical School
The Wall Street Journal, 11/17/09
The Dean of the Harvard Medical School gives the health reform debate a failing grade. In this commentary, he writes that those for whom the central issue is health -- not politics -- have been left in the lurch. Our health care system suffers from problems of cost, access and quality, and needs major reform. Tax policy drives employment-based insurance; this begets overinsurance and drives costs upward while creating inequities for the unemployed and self-employed. A regulatory morass limits innovation. And deep flaws in Medicare and Medicaid drive spending without optimizing care. Speeches and news reports can lead you to believe that proposed congressional legislation would tackle the problems of cost, access and quality. But that's not true. The various bills do deal with access by expanding Medicaid and mandating subsidized insurance at substantial cost -- and thus addresses an important social goal. However, there are no provisions to substantively control the growth of costs or raise the quality of care. So the overall effort will fail to qualify as reform. Read More »
Read more about health reform proposals on the Health Reform Hub >>
back to top 
MEDICAID
Medicaid: The Forgotten Issue in Health Reform
Robert B. Helms
American Enterprise Institute, 11/09
Instead of making simple reforms to the way federal funds are distributed for Medicaid, current health care legislation seeks only to expand the program, Helms writes. The present growth of federal expenditures on Medicaid is not sustainable, however. In order to ensure that the people who most need assistance for health care continue to receive it, Congress should be making fundamental reforms to the Medicaid program first. These include giving block grants to the states, reforming the federal matching-rate formula, and reducing marginal incentives to expand Medicaid. Read More »
Explore Medicaid issues on the Health Reform Hub >>
back to top 
INNOVATION
Bending the Productivity Curve: Why America Leads the World in Medical Innovation
Glen Whitman, California State University and Raymond Raad, New York Presbyterian Hospital/Weill Cornell Medical Center
Cato Institute, 11/18/09
In three of the four general categories of innovation examined in this paper -- basic science, diagnostics, and therapeutics -- the U.S. has contributed more than any other country, and in some cases, more than all other countries combined, Whitman and Raad write. In general, Americans tend to receive more new treatments and pay more for them -- a fact that is usually regarded as a fault of the American system. That interpretation, if not entirely wrong, is at least incomplete. Rapid adoption and extensive use of new treatments and technologies create an incentive to develop those techniques in the first place. When the U.S. subsidizes medical innovation, the whole world benefits. That is a virtue of the American system not reflected in comparative life expectancy and mortality statistics. Read More »
Read more about innovation in the health sector on the Health Reform Hub >>
back to top 
|